Patent Assignment
Reel/Frame 038989/0761
Assignment of Assignor's Interest
Recorded: 2016-06-22
Pages: 6
Assignors
CHAPLIN, DAVID J.
Executed: 2002-12-10
PREZIOSO, JOSEPH ANTHONY
Executed: 2002-12-10
EDVARDSEN, KLAUS
Executed: 2003-01-15
Assignee
OXIGENE, INC.
701 GATEWAY BOULEVARD, SUITE 210, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties
(2)
Functionalized Stilbene Derivatives as Improved Vascular Targeting Agents
Patent:
45,720 →
Application:
14/180,209 →
Functionalized Stilbene Derivatives as Improved Vascular Targeting Agents
Patent:
45,907 →
Application:
14/180,238 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 22, 2016
From: GARNER, CHARLES M., III; KANE, ROBERT R.; PINNEY, KEVIN G.
To: BAYLOR UNIVERSITY
Reel/Frame 038989/0795 →
Corrective Assignment to Correct the Correct Application No. 14/108,238 to 14/180,238 Previously Recorded on Reel 038989 Frame 0761. Assignor(S) Hereby Confirms the Assignment.
Jun 29, 2016
From: CHAPLIN, DAVID J.; PREZIOSO, JOSEPH ANTHONY; EDVARDSEN, KLAUS
To: OXIGENE, INC.
Reel/Frame 039207/0299 →
Change of Name
Jul 26, 2016
From: OXIGENE, INC.
To: MATEON THERAPEUTICS, INC.
Reel/Frame 039264/0377 →